The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReach Plc Regulatory News (RCH)

Share Price Information for Reach Plc (RCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 71.50
Bid: 70.90
Ask: 71.40
Change: 2.30 (3.32%)
Spread: 0.50 (0.705%)
Open: 70.60
High: 71.50
Low: 69.10
Prev. Close: 69.20
RCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

10 Oct 2023 07:00

RNS Number : 4821P
Reach PLC
10 October 2023

10 October 2023

Reach plc ("The Company") Q3 Trading update for the 3-month period to 24 September 2023

Full year profit expectations unchanged

Q3 YOY %

9 Months YOY %

Digital revenue

(13.7)

(15.2)

Print revenue

(5.8)

(3.8)

- Circulation revenue

(3.3)

0.4

- Advertising revenue

(8.9)

(15.7)

Group revenue

(7.8)

(6.6)

The factors affecting Q3 digital revenue are unchanged from those outlined in our half year results. These include depressed open market yields and the well-publicised declining digital referral volumes, in particular from Facebook's de-prioritisation of news. As a result over the nine-month period, year-on-year page views declined 21%. Data driven revenue,1 which is higher value and more targeted, continues to be robust and now makes up a larger part of digital revenues at 42%. (FY 2019 - 24%)

In print, circulation revenue has grown marginally over the first 9 months of the year. This remains a resilient and predictable revenue stream as we actively mitigate the expected volume decline. Last September 2022 saw modest advertising activity following the Queen's death, excluding this one-off factor the quarter would trend in line with the 9-month movement. Brands continue to value advertising to our substantial customer base.

Capital reduction

The Company announces that it will in due course be posting a circular to shareholders (including notice of general meeting) in connection with a proposed capital reduction of £605.4m. This is conditional upon the approval of the Company's shareholders and by the High Court of Justice in England and Wales. The Capital Reduction will not involve any return of capital or payment to shareholders but will create additional distributable reserves.2

MGN Pension scheme resolution

We are pleased to report that we have now concluded the 2019 triennial valuation for the MGN scheme, and at the same time concluded its 2022 triennial valuation. The funding valuation of the MGN scheme at 31 December 2022 showed a deficit of £219.0m. This deficit is expected to be removed via a schedule of contributions that includes annual payments of £46.0m pa from January 2023 until January 2028. The previous schedule of contributions for the MGN scheme included payments of £40.9m pa from 2023 to 20273. Discussions are ongoing with the Group's other schemes in relation to the 2022 triennial valuations and are expected to be concluded satisfactorily by the 31 March 2024 due date.

Outlook

We remain confident of meeting profit expectations for the full year.4 We do not anticipate the market backdrop to change materially in the near term and as a result we remain focused on the areas within our control; improving customer engagement, diversifying revenues and driving efficiencies. Our plans to reduce full year operating costs by 5-6% remain on track. We expect a High Court judgement on time limitation relating to historical legal issues in the next few months.

Jim Mullen Chief Executive

"This quarter we see continued evidence that our data driven strategy is working, supported by our resilient print business. Through this challenging period we have remained focused on the controllables. We are delivering our Customer Value Strategy and have made progress diversifying our audience. We continue to review our cost base so that we can accelerate our digital transformation."

Notes

1

Includes revenue from advertising activity which utilises data generated via registrations, audience behavioural or Mantis contextual. It also includes other strategically driven revenues, less dependent on audience volumes such as affiliates, partnerships and ecommerce.

2

This change will result in £605.4m cancellation of the Company's share premium account and the creation of distributable reserves of the same amount.

3

Previous MGN schedule of contributions disclosed in the Half year report - 25 July 2023.

4

Market expectations compiled by the Company are an average of analyst published forecasts - consensus adjusted operating profit for FY23 £95.0m.

Enquiries

Reach

communications@reachplc.com

Jim Mullen, Chief Executive Officer

Darren Fisher, Chief Financial Officer

Lorraine Clover, Group Company Secretary

Lija Kresowaty, Head of External Communications

Jo Britten, Investor Relations Director

+44 (0)7557 557447

Teneo

reachplc@teneo.com

David Allchurch/Giles Kernick

+44 (0)207 353 4200

About Reach

We're Reach plc, the UK's and Ireland's largest commercial news publisher. We're home to more than 130 trusted brands, from national titles like the Mirror, Express, Daily Record and Daily Star, to local brands like MyLondon, BelfastLive and the Manchester Evening News, to our recently launched U.S. titles. Every month, 48 million people come to us, via print and online, for trusted news, entertainment and sport.

LEI: 213800GNI5XF3XOATR61

Classification: 3.1 Additional regulated information required to be disclosed under the laws of the United

Kingdom

The information in the section of the announcement headed "MGN Pension scheme resolution" in relation

to the conclusion of the 2019 and 2022 triennial valuations for the MGN scheme is inside

information disclosed under article 7 of the Market Abuse Regulation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTFSEESUEDSESS
Date   Source Headline
18th Apr 20241:00 pmRNSHolding(s) in Company
27th Mar 202411:21 amRNSNotice of Meeting
19th Mar 202412:30 pmRNSAnnual Report Publication
5th Mar 20247:00 amRNSAnnual Results for 53 weeks ended 31 December 2023
20th Feb 202411:30 amRNSNotice of Results
1st Feb 202411:00 amRNSTVR announcement
21st Dec 20231:30 pmRNSCapital Reduction becomes effective
15th Dec 202311:40 amRNSReach plc update on Historical Legal Issues
13th Dec 20239:00 amRNSPriya Guha - change in director particulars
21st Nov 20239:00 amRNSDenise Jagger - change in director particulars
15th Nov 20231:30 pmRNSResult of General Meeting
8th Nov 20237:00 amRNSReach plc announces cost reduction programme
1st Nov 202311:00 amRNSTotal Voting Rights
20th Oct 202311:30 amRNSNotice of GM
10th Oct 20237:00 amRNSTrading Update
2nd Oct 202311:00 amRNSTotal Voting Rights
1st Sep 202311:00 amRNSTotal Voting Rights
17th Aug 202311:00 amRNSHolding(s) in Company
1st Aug 202311:00 amRNSTotal Voting Rights
25th Jul 20237:00 amRNSHalf-year Report
7th Jul 202311:00 amRNSAppointment of Joint Broker
4th Jul 20234:00 pmRNSNotice of Results
3rd Jul 202311:00 amRNSTotal Voting Rights
23rd Jun 202311:00 amRNSDirector/PDMR Shareholding
6th Jun 20231:00 pmRNSDirector/PDMR Shareholding
1st Jun 202311:00 amRNSTotal Voting Rights
3rd May 20232:00 pmRNSResult of AGM
3rd May 20237:00 amRNSTrading Update
2nd May 202311:00 amRNSTotal Voting Rights
14th Apr 202311:00 amRNSDirector/PDMR Shareholding
14th Apr 20239:00 amRNSResignation of Non-Executive Director
31st Mar 202310:00 amRNSReach plc - Notice of AGM
28th Mar 202311:00 amRNSDirector/PDMR Shareholding
21st Mar 20232:00 pmRNSLTIP - Waiver of Award - Jim Mullen
21st Mar 202312:16 pmRNSAnnual Report and Accounts
7th Mar 20237:00 amRNSAnnual Results for 52 weeks ended 25 December 2022
24th Feb 202311:00 amRNSNotice of Results
13th Jan 202312:00 pmRNSHolding(s) in Company
12th Jan 20234:30 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSTrading Update
3rd Jan 202311:30 amRNSTotal Voting Rights
21st Dec 202211:00 amRNSBoard Changes
20th Dec 20221:00 pmRNSDirector/PDMR Shareholding
16th Dec 202211:30 amRNSDirector/PDMR Shareholding
6th Dec 202211:00 amRNSTransfer of Treasury Shares
28th Nov 202211:00 amRNSDirector/PDMR Shareholding
24th Nov 20223:20 pmRNSForm 8.3 - Reach PLC
24th Nov 202210:55 amRNSForm 8.5 (EPT/RI) - Reach PLC
23rd Nov 20221:00 pmRNSResponse to statement by National World plc
23rd Nov 202211:30 amRNSStatement re Possible Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.